Partnerships & Affiliations

Stay Connected

Stay connected to the issues that affect you most. Subscribe, follow or become a fan of ACRO. 

  Find Us on Facebook  Find Us on LinkedIn  

Home » About ACRO » Partnerships & Affiliations

Partnerships & Affiliations

Partnerships & Affiliations

ACRO represents it members in a number of public-private partnerships, industry coalitions and complementary associations. Participation in these organizations provides an additional benefit to ACRO members. ACRO joins various groups to foster cross-industry cooperation, promote policy positions and create business development opportunities for its members. Below are links to groups in which ACRO is actively involved.

Coalitions, Advocacy and Education

The Association of Clinical Researchers and Educators (ACRE) is an organization of medical professionals dedicated to the advancement of patient care through productive collaboration with industry and its counterparts.

The Alliance for a Stronger FDA was formed to work for increased appropriations to strengthen the FDA. 

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies—funding, regulatory, reimbursement and others—to facilitate advances in the field.

The Alliance for Safe Biologic Medicines (ASBM) The Alliance for Safe Biologic Medicines is an organization composed of diverse healthcare groups and individuals—from patients to physicians, biotechnology companies that develop innovative and biosimilar medicines and others who are working together to ensure patient safety is at the forefront of the biosimilars policy discussion

The Center for Information and Study on Clinical Research Participation (CISCRP) is a first-of-its-kind nonprofit organization dedicated to educating and informing the public, patients, medical/research communities, the media and policy makers about clinical research and the role each party plays in the process.

The Healthcare Leadership Council (HLC), a coalition of chief executives from all disciplines within American healthcare, is the exclusive forum for the nation’s healthcare leaders to jointly develop policies, plans, and programs to achieve their vision of a 21st century system that makes affordable, high-quality care accessible to all Americans. 

Members of the International Pharmaceutical Privacy Consortium (IPPC) are actively addressing data privacy and security issues around the world, assessing and minimizing risks, and creating practical standards for industry performance.

The European Forum for Good Clinical Practice (EFGCP) is a non-profit organization established by and for individuals with a professional involvement in the conduct of biomedical research.

The Partnership to Improve Patient Care exists to advance proposals for comparative effectiveness research (CER) that are focused on supporting providers and patients with the information they need, improving health care quality and supporting continued medical progress.

The U.S. Chamber of Commerce is the world's largest business federation representing the interests of more than 3 million businesses of all sizes, sectors, and regions, as well as state and local chambers and industry associations.

The R&D Credit Coaltion The R&D Credit Coalition is a group of more than 100 trade and professional associations along with small, medium and large companies that collectively represent millions of American workers engaged in U.S.-based research throughout major sectors of the U.S. economy, including aerospace, agriculture, biotechnology, chemicals, electronics, energy, information technology, manufacturing, medical technology, pharmaceuticals, software and telecommunications.

Government-Industry Collaborations

The Biomarkers Consortium is a public-private biomedical research partnership managed by the Foundation for the National Institutes of Health (FNIH) that endeavors to develop, validate and qualify biological markers (biomarkers) to speed the development of medicines and therapies for detection, prevention, diagnosis and treatment of disease and improve patient care.

The Clinical Trial Transformation Initiative (CTTI) is a public-private partnership that brings together all interested stakeholders to identify practices that through broad adoption will increase the quality and efficiency of clinical trials.

The MHRA Good Clinical Practice (GCP) Consultative Committee is organized by the MHRA's CGP Inspectorate, which assesses the compliance of organizations conducting clinical trials using investigational medicinal products with UK and EU legislation.

Standards Setting Organizations

The Clinical Data Interchange Standards Consortium (CDISC) is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. 

Clinical Data Acquisition Standards Harmonization (CDASH) is a CDISC-led collaborative initiative to develop content standards for basic global data collection fields that support clinical research studies. 

The Metrics Champion Consortium develops performance metrics within the biotechnology and pharmaceutical industry to jointly encourage performance improvement, effectiveness, efficiency and appropriate levels of controls in support of the drug development process.

For links to information on regulations and policies governing clinical research worldwide, click here.